fluorodeoxyglucose f18 has been researched along with Day Blindness in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Grauer, O; Lohmann, L; Meuth, SG; Nelke, C; Obergassel, J; Wiendl, H | 1 |
| Caterson, HC; Sammel, AM; Shah, PR; Wegner, EA | 1 |
| Bailey, DL; Bailey, E; Dunn, H; Farmakis, P; Fraser, CL; Hsiao, E; Janssen, B; Kuo, CH; Laurent, R; Nguyen, K; Roach, P; Sammel, AM; Schembri, G; Schrieber, L; Youssef, P | 1 |
| Chen, CL; Chen, JT; Chen, YH; Huang, KH; Lee, LC; Lin, LF; Lu, DW; Tai, MC; Weng, TH | 1 |
| Kornberg, MD; Probasco, JC; Ratchford, JN; Subramaniam, RM | 1 |
| Ishii, K; Ishiwata, K; Kiyosawa, M; Murai, H; Suzuki, Y; Tokumaru, AM | 1 |
| Imai, M; Ishibashi, K; Ishii, K; Tanaka, M; Tokumaru, A | 1 |
| Finelli, PF | 1 |
| Hattori, N; Ishii, K; Kambe, T; Motoi, Y | 1 |
| Berding, G; Garde, N; Pul, R; Skripuletz, T; Trebst, C; Weissenborn, K | 1 |
| Arruga, J; Campdelacreu, J; Gascon-Bayarri, J; Juncadella, M; Muñoz, S; Reñé, R; Rico, I | 1 |
| Caine, D; Clarke, J; Fryer, TD; Hodges, JR; Nestor, PJ | 1 |
| Lee, AG; Martin, CO | 1 |
| Galldiks, N; Grond, M; Hilker, R; Jacobs, AH; Klein, JC; Thomas, A | 1 |
| Sun, JG; Wong, VC; Yeung, DW | 1 |
| Bateman, JB; Chugani, HT; Philippart, M | 1 |
| Ito, M; Kiyosawa, M; Nakagawa, Y; Tamai, M | 1 |
| Alexander, GE; Dani, A; Freo, U; Furey, ML; Grady, CL; Graff-Radford, N; Mentis, MJ; Pietrini, P; Schapiro, MB | 1 |
| Alavi, A; Bosley, TM; Burke, A; Cobbs, W; Dann, R; Kushner, M; Rosenquist, AC; Savino, PJ; Schatz, NJ; Stein, A | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Day Blindness
| Article | Year |
|---|---|
Positron emission tomography/computed tomography scan of Vogt-Koyanagi-Harada syndrome with associated autoimmune thyroid disease: A case report and literature review.
Topics: Female; Fluorodeoxyglucose F18; Glucocorticoids; Headache; Humans; Methylprednisolone; Middle Aged; Positron Emission Tomography Computed Tomography; Thyroiditis, Autoimmune; Uveomeningoencephalitic Syndrome; Vision Disorders | 2018 |
1 trial(s) available for fluorodeoxyglucose f18 and Day Blindness
| Article | Year |
|---|---|
Pilot study of efficacy of tongue and body acupuncture in children with visual impairment.
Topics: Acupuncture Therapy; Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Glucose; Humans; Infant; Male; Occipital Lobe; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tongue; Treatment Outcome; Vision Disorders | 2006 |
17 other study(ies) available for fluorodeoxyglucose f18 and Day Blindness
| Article | Year |
|---|---|
An enigmatic case of cortical anopsia: Antemortem diagnosis of a 14-3-3 negative Heidenhain-variant MM1-sCJD.
Topics: 14-3-3 Proteins; Aged, 80 and over; Cerebral Cortex; Creutzfeldt-Jakob Syndrome; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Vision Disorders | 2020 |
Ophthalmic Inflammation on Positron Emission Tomography in Vision-Threatening Giant Cell Arteritis.
Topics: Aged; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Medical Illustration; Positron-Emission Tomography; Radiopharmaceuticals; Retinal Artery; Vision Disorders | 2020 |
Fluorine-18 Fluoro-2-Deoxyglucose Positron Emission Tomography Uptake in the Superficial Temporal and Vertebral Arteries in Biopsy Positive Giant Cell Arteritis.
Topics: Aged; Diagnostic Techniques, Ophthalmological; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Temporal Arteries; Vertebral Artery; Vision Disorders | 2017 |
Giant cell arteritis mimicking infiltrative leptomeningeal disease of the optic nerves.
Topics: Aged; Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Meningeal Carcinomatosis; Methylprednisolone; Optic Nerve; Positron-Emission Tomography; Temporal Arteries; Vision Disorders | 2015 |
Cerebral glucose metabolism in the striate cortex positively correlates with fractional anisotropy values of the optic radiation in patients with glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Anisotropy; Blood Glucose; Case-Control Studies; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Glaucoma; Glucose Metabolism Disorders; Humans; Male; Middle Aged; Optic Nerve Diseases; Positron-Emission Tomography; Prospective Studies; Vision Disorders; Visual Cortex; Visual Field Tests; Visual Fields | 2015 |
Glucose Hypometabolism in Developmental Venous Anomaly Without Apparent Parenchymal Damage.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Intracranial Arteriovenous Malformations; Male; Parenchymal Tissue; Positron-Emission Tomography; Radiopharmaceuticals; Vision Disorders | 2017 |
Positron emission tomography in diagnosis of visual variant Alzheimer disease.
Topics: Aged; Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Vision Disorders | 2009 |
Posterior cortical atrophy with [11C] Pittsburgh compound B accumulation in the primary visual cortex.
Topics: Aniline Compounds; Atrophy; Brain Mapping; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Hemianopsia; Humans; Magnetic Resonance Imaging; Middle Aged; Neurofibrillary Tangles; Plaque, Amyloid; Positron-Emission Tomography; Predictive Value of Tests; Thiazoles; Vision Disorders; Visual Cortex | 2010 |
Visual hallucinations in Charles Bonnet syndrome can be seen in fluorodeoxyglucose-PET.
Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hallucinations; Humans; Positron-Emission Tomography; Vision Disorders | 2011 |
Complex visual manifestations of posterior cortical atrophy.
Topics: Aged; Atrophy; Brain Diseases; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Retrospective Studies; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Vision Disorders | 2012 |
The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET.
Topics: Aged; Alzheimer Disease; Atrophy; Brain Mapping; Case-Control Studies; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Vision Disorders; Visual Perception | 2003 |
Neuro-ophthalmic findings in the visual variant of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Blindness, Cortical; Female; Fluorodeoxyglucose F18; Hemianopsia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Occipital Lobe; Parietal Lobe; Retrospective Studies; Tomography, Emission-Computed; Vision Disorders; Visual Field Tests; Visual Fields | 2004 |
Multitracer PET imaging in Heidenhain variant of Creutzfeldt-Jakob disease.
Topics: Adult; Creutzfeldt-Jakob Syndrome; Diffusion Magnetic Resonance Imaging; Electroencephalography; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Occipital Lobe; Positron-Emission Tomography; Radioisotopes; Vision Disorders | 2006 |
New Spielmeyer-Vogt variant with granular inclusions and early brain atrophy.
Topics: Adult; Atrophy; Brain; Child; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Genetic Variation; Humans; Inclusion Bodies; Learning Disabilities; Neuronal Ceroid-Lipofuscinoses; Nuclear Family; Tomography, Emission-Computed; Vision Disorders | 1995 |
Positron emission tomography and 18F-fluorodeoxyglucose for the detection of visual pathway abnormalities in albinism.
Topics: Adolescent; Adult; Albinism, Ocular; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Tomography, Emission-Computed; Vision Disorders; Visual Pathways | 1993 |
Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
Topics: Aged; Alzheimer Disease; Brain; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Prognosis; Psychomotor Performance; Tomography, Emission-Computed; Vision Disorders; Visual Cortex | 1996 |
Ischemic lesions of the occipital cortex and optic radiations: positron emission tomography.
Topics: Adult; Aged; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Ischemic Attack, Transient; Male; Middle Aged; Occipital Lobe; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vision Disorders; Visual Cortex; Visual Pathways | 1985 |